Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Plant Breeding and Biotechnology01:59

Plant Breeding and Biotechnology

Crop cultivation has a long history in human civilization, with records showing the cultivation of cereal plants beginning at around 8000 BC. This early plant breeding was developed primarily to provide a steady supply of food.
Synthetic Biology02:55

Synthetic Biology

Synthetic biology is an interdisciplinary science that involves using principles from disciplines such as engineering, molecular biology, cell biology, and systems biology. It involves remodeling existing organisms from nature or constructing completely new synthetic organisms for applications such as protein or enzyme production, bioremediation, value-added macromolecule production, and the addition of desirable traits to crops, to name a few.
Golden rice
Golden rice is a genetically modified...
Drug Products: Biologics, Biosimilars and Interchangeables01:28

Drug Products: Biologics, Biosimilars and Interchangeables

Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
Biopharmaceutical Factors Influencing Drug Product Design: Overview01:22

Biopharmaceutical Factors Influencing Drug Product Design: Overview

Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though pharmacologically...
Upstream Processing01:27

Upstream Processing

Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
Production of Biopesticides01:18

Production of Biopesticides

Biopesticides offer a sustainable alternative to chemical pesticides, utilizing microbial agents to control agricultural pests. Bacillus thuringiensis (Bt) is a widely employed bacterium known for its potent insecticidal activity. Bt biopesticides are favored for their specificity to insect pests, minimal environmental impact, and natural degradability.Mechanism of Bt Toxin Action Bt produces insecticidal crystal (Cry) proteins during its sporulation phase. These proteins form parasporal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Process dissociation of sight vocabulary and phonetic decoding in reading: a new perspective on surface and phonological dyslexias.

Brain and language·2005
Same author

Preparing medical students for the changing healthcare environment in United States.

The Journal of the American Osteopathic Association·2000
Same author

Preliminary survey of pharmacists' use of the Internet.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·1999
Same author

Innovation at Midwestern.

Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)·1998
Same author

First-language acquisition in adolescence: evidence for a critical period for verbal language development.

Brain and language·1998
Same author

Motivations and practice-area preferences of pharmacists interested in pursuing a Pharm.D. degree through a nontraditional program.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·1998

Related Experiment Video

Updated: Jun 21, 2026

The MultiBac Protein Complex Production Platform at the EMBL
13:51

The MultiBac Protein Complex Production Platform at the EMBL

Published on: July 11, 2013

How a collaborative task force can assist in managing biotechnology products.

G E MacKinnon1

  • 1St. Louis College of Pharmacy.

Hospital Formulary
|July 1, 1994
PubMed
Summary

Biotechnology-derived pharmaceuticals present challenges in healthcare. A task force improved understanding and management of these advanced therapies, establishing a beneficial process for future biopharmaceutical evaluations.

Area of Science:

  • Pharmaceutical Science
  • Health Policy
  • Biotechnology

Background:

  • The increasing prevalence of biotechnology-derived pharmaceuticals introduces complexities in healthcare management, including formulary decisions, usage protocols, and financial planning.
  • Existing healthcare systems face challenges in adapting to the unique needs of biopharmaceuticals.

Purpose of the Study:

  • To establish a collaborative forum for healthcare professionals and administrators to address challenges posed by biopharmaceuticals.
  • To develop and implement a strategic framework for evaluating and forecasting the utilization of biopharmaceuticals.
  • To enhance educational initiatives and database infrastructure for effective biopharmaceutical management and monitoring.

Main Methods:

  • Formation of a Biotechnology Task Force by a DUE/QA pharmacy network and a hospital association.

More Related Videos

The Development and Application of Biophysical Assays for Evaluating Ternary Complex Formation Induced by Proteolysis Targeting Chimeras (PROTACS)
07:22

The Development and Application of Biophysical Assays for Evaluating Ternary Complex Formation Induced by Proteolysis Targeting Chimeras (PROTACS)

Published on: January 12, 2024

Bioassay-Guided Identification of Natural Products for Biocontrol by Thin Layer Chromatography-Direct Bioautography
04:52

Bioassay-Guided Identification of Natural Products for Biocontrol by Thin Layer Chromatography-Direct Bioautography

Published on: July 26, 2024

Related Experiment Videos

Last Updated: Jun 21, 2026

The MultiBac Protein Complex Production Platform at the EMBL
13:51

The MultiBac Protein Complex Production Platform at the EMBL

Published on: July 11, 2013

The Development and Application of Biophysical Assays for Evaluating Ternary Complex Formation Induced by Proteolysis Targeting Chimeras (PROTACS)
07:22

The Development and Application of Biophysical Assays for Evaluating Ternary Complex Formation Induced by Proteolysis Targeting Chimeras (PROTACS)

Published on: January 12, 2024

Bioassay-Guided Identification of Natural Products for Biocontrol by Thin Layer Chromatography-Direct Bioautography
04:52

Bioassay-Guided Identification of Natural Products for Biocontrol by Thin Layer Chromatography-Direct Bioautography

Published on: July 26, 2024

  • Development of information exchange forums for practitioners and administrators.
  • Implementation of strategies for evaluating and predicting biopharmaceutical usage patterns.
  • Creation of database technology for institutional usage monitoring.
  • Main Results:

    • Successful education of healthcare professionals and administrators regarding the implications of biopharmaceuticals.
    • Establishment of a defined process for the evaluation and management of biopharmaceuticals.
    • Facilitation of information exchange and collaborative problem-solving.

    Conclusions:

    • The established process provides a valuable framework for the future evaluation of emerging biopharmaceuticals.
    • Proactive collaboration and strategic planning are essential for integrating novel biotechnologies into healthcare.
    • The task force model demonstrated effectiveness in addressing the complexities of biopharmaceutical adoption.